Multiple myeloma is a cancer of plasma cells in the bone marrow. It can affect bone strength, blood-cell production, kidney function and resistance to infection. Treatment is directed by a hematology or oncology team and depends on the disease and the patient's circumstances.
HBOT is not an established treatment for the myeloma itself. A person with myeloma may have a separate complication that warrants hyperbaric assessment, but the specific diagnosis matters. For example, exceptional severe anemia when transfusion cannot be used is different from routine cancer-related fatigue or anemia. Radiation-related tissue damage is also distinct from medication-related jaw problems. Claims of benefit should be tied to the actual complication and its evidence, without delaying cancer treatment.
Cancer arising in breast tissue, with treatment tailored to the tumour type, stage and individual patient.
A group of diseases in which abnormal cells grow uncontrollably and may invade or spread to other tissues.
Late tissue damage after radiation therapy that can cause poor healing, fibrosis or tissue breakdown.
A cancer of plasma cells in the bone marrow that can affect bones, blood counts, kidneys and immunity.
A severe shortage of red blood cells or hemoglobin that reduces the body's ability to deliver oxygen.
.svg)